Enb Therapeutics, Inc. announced it raised $2.29 Million in an initial filing from an offering of $9.09 Million

Sep 21, 2018•almost 7 years ago

Amount Raised

$2.29 Million

Round Type

seed

New YorkBiotechnology

Company Information

Company

ENB Therapeutics, Inc.

Location

C/O LAUNCHLABS

New York, New York, United States

About

ENB Therapeutics is developing therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.

Medium Activity

Get personalized insights on buying likelihood